Jean Paul Guthmann

Summary

Publications

  1. ncbi Environmental risk factors for clinical malaria: a case-control study in the Grau region of Peru
    J P Guthmann
    Department of Infectious and Tropical Disease, Infectious Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, UK
    Trans R Soc Trop Med Hyg 95:577-83. 2001
  2. ncbi Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru
    Jean Paul Guthmann
    Epicentre, Paris, France
    Trop Med Int Health 10:856-62. 2005
  3. ncbi High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola
    Jean Paul Guthmann
    Epicentre, Paris, France Médecins Sans Frontières, Paris, France
    Am J Trop Med Hyg 75:143-5. 2006
  4. ncbi A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods
    Jean Paul Guthmann
    Epicentre, Paris, France
    Clin Infect Dis 42:1685-91. 2006
  5. ncbi Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004
    Jean Paul Guthmann
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Antimicrob Agents Chemother 50:3734-9. 2006
  6. ncbi The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos
    J P Guthmann
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Ann Trop Med Parasitol 96:553-7. 2002
  7. ncbi Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda
    J P Guthmann
    Epicentre, 4 rue Saint Sabin, 75011 Paris, France
    Trans R Soc Trop Med Hyg 96:254-7. 2002
  8. ncbi Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru
    J P Guthmann
    Infectious and Tropical Disease Department, Infectious Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, England
    Trop Med Int Health 7:518-25. 2002
  9. ncbi Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola
    Jean Paul Guthmann
    Epicentre, 42 bis, Boulevard Richard Lenoir, 75011 Paris, France
    Trans R Soc Trop Med Hyg 99:485-92. 2005
  10. ncbi Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
    Francesco Checchi
    Epicentre, Paris, France
    Malar J 5:59. 2006

Detail Information

Publications44

  1. ncbi Environmental risk factors for clinical malaria: a case-control study in the Grau region of Peru
    J P Guthmann
    Department of Infectious and Tropical Disease, Infectious Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, UK
    Trans R Soc Trop Med Hyg 95:577-83. 2001
    ..Based on these results we discuss possible control measures for malaria in this area of the country...
  2. ncbi Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, Peru
    Jean Paul Guthmann
    Epicentre, Paris, France
    Trop Med Int Health 10:856-62. 2005
    ..This should allow the treatment of a significant number of additional patients, while saving money to invest in other facets of the case management...
  3. ncbi High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola
    Jean Paul Guthmann
    Epicentre, Paris, France Médecins Sans Frontières, Paris, France
    Am J Trop Med Hyg 75:143-5. 2006
    ..1% to 15.9%). Our findings are in favor of a high efficacy of both combinations in Caala. Now that Coartem has been chosen as the new first-line anti-malarial, the challenge is to insure that this drug is available and adequately used...
  4. ncbi A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods
    Jean Paul Guthmann
    Epicentre, Paris, France
    Clin Infect Dis 42:1685-91. 2006
    ..The conflict in Darfur, Sudan, was responsible for the displacement of 1.8 million civilians. We investigated a large outbreak of hepatitis E virus (HEV) infection in Mornay camp (78,800 inhabitants) in western Darfur...
  5. ncbi Methodological issues in the assessment of antimalarial drug treatment: analysis of 13 studies in eight African countries from 2001 to 2004
    Jean Paul Guthmann
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Antimicrob Agents Chemother 50:3734-9. 2006
    ..Results support the implementation of the current WHO protocol and favor analyzing PCR-corrected outcomes by Kaplan-Meier analysis (which allows for dropouts) and retaining new infections (which minimizes losses)...
  6. ncbi The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos
    J P Guthmann
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Ann Trop Med Parasitol 96:553-7. 2002
    ..7%, with a 95% confidence interval of 29.5%-50.7%) of these 88 patients were considered treatment failures. These results seriously question the use of chloroquine as the first-line treatment for P. falciparum malaria in the study area...
  7. ncbi Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda
    J P Guthmann
    Epicentre, 4 rue Saint Sabin, 75011 Paris, France
    Trans R Soc Trop Med Hyg 96:254-7. 2002
    ..97), easy to use and cheap (about US$ 0.5/test). The ParaHIT f represented a good alternative...
  8. ncbi Environmental factors as determinants of malaria risk. A descriptive study on the northern coast of Peru
    J P Guthmann
    Infectious and Tropical Disease Department, Infectious Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, England
    Trop Med Int Health 7:518-25. 2002
    ..These observations were extended through an entomological study and a case-control study, to be published elsewhere...
  9. ncbi Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquine + artesunate and sulfadoxine-pyrimethamine + artesunate in Huambo and Bie provinces, central Angola
    Jean Paul Guthmann
    Epicentre, 42 bis, Boulevard Richard Lenoir, 75011 Paris, France
    Trans R Soc Trop Med Hyg 99:485-92. 2005
    ..We recommend the use of AQ with AS, though this combination might not have a long useful therapeutic life because of AQ resistance...
  10. ncbi Supervised versus unsupervised antimalarial treatment with six-dose artemether-lumefantrine: pharmacokinetic and dosage-related findings from a clinical trial in Uganda
    Francesco Checchi
    Epicentre, Paris, France
    Malar J 5:59. 2006
    ....
  11. ncbi Adherence to the combination of sulphadoxine-pyrimethamine and artesunate in the Maheba refugee settlement, Zambia
    Evelyn Depoortere
    Epicentre, Paris, France
    Trop Med Int Health 9:62-7. 2004
    ..For these treatment regimens to remain efficacious on a long-term basis, specific and locally adapted strategies need to be implemented to ensure completion of the treatment...
  12. ncbi Antimalarial efficacy of sulfadoxine-pyrimethamine, amodiaquine and a combination of chloroquine plus sulfadoxine-pyrimethamine in Bundi Bugyo, western Uganda
    Francesco Checchi
    Epicentre, Paris, France
    Trop Med Int Health 9:445-50. 2004
    ..Our study also confirms previous findings that resistance is considerably underestimated by 14-day follow-ups. Antimalarial policy decisions should therefore be based on 28-day studies, with PCR adjustment to distinguish re-infections...
  13. ncbi Efficacy and effectiveness of the combination of sulfadoxine/pyrimethamine and a 3-day course of artesunate for the treatment of uncomplicated falciparum malaria in a refugee settlement in Zambia
    Evelyn Depoortere
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Trop Med Int Health 10:139-45. 2005
    ..When implementing new malaria treatment policies, serious investment in ensuring patient adherence is essential to ascertain the effectiveness of the new treatment schedules...
  14. ncbi Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children
    Elizabeth A Ashley
    Epicentre, Paris, France
    Malar J 7:154. 2008
    ..Use of different methods for assessing the efficacy of artemisinin-based combination antimalarial treatments (ACTs) will result in different estimates being reported, with implications for changes in treatment policy...
  15. ncbi Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré
    Maryline Bonnet
    Epicentre, 8, Paris, France
    Malar J 6:54. 2007
    ..Two studies were conducted in 2004/2005 in programmes supported by Medecins Sans Frontieres, when chloroquine was still national policy, but artesunate (AS)/sulphadoxine-pyrimethamine (SP) had been used in refugee camps for two years...
  16. ncbi Artesunate and sulfadoxine-pyrimethamine combinations for the treatment of uncomplicated Plasmodium falciparum malaria in Uganda: a randomized, double-blind, placebo-controlled trial
    Gerardo Priotto
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Trans R Soc Trop Med Hyg 97:325-30. 2003
    ..Treatment efficacy improved with SPAS3 but the cure rate at day 28 was modest. The combinations were well tolerated and safe. In areas where SP resistance is prevalent other combinations should be considered...
  17. ncbi Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali
    Xavier de Radiguès
    Epicentre, 42 bis, Boulevard Richard Lenoir, 75011 Paris, France
    Trans R Soc Trop Med Hyg 100:1013-8. 2006
    ..The use of SP in monotherapy is likely to compromise its efficacy. We recommend the use of artemisinin-based combination therapy as first-line treatment for uncomplicated Plasmodium falciparum malaria in Koumantou...
  18. ncbi Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria
    Richard J Pearce
    London School of Hygiene and Tropical Medicine, Department of Infectious Tropical Diseases, London, UK
    PLoS Med 6:e1000055. 2009
    ..To that end we have characterised the evolutionary origins of antifolate resistance mutations in the dihydropteroate synthase (dhps) gene and mapped their contemporary distribution...
  19. ncbi Efficacy of chloroquine, sulfadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria among children under five in Bongor and Koumra, Chad
    Francesco Grandesso
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Trans R Soc Trop Med Hyg 100:419-26. 2006
    ..Nevertheless, the efficacy of this combination should be evaluated and the change carefully prepared, implemented and monitored...
  20. ncbi Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial
    Patrice Piola
    Epicentre, 8 rue Saint Sabin, 75011 Paris, France
    Lancet 365:1467-73. 2005
    ....
  21. ncbi Community coverage of an antimalarial combination of artesunate and amodiaquine in Makamba Province, Burundi, nine months after its introduction
    Sibylle Gerstl
    Epicentre, Paris, France
    Malar J 6:94. 2007
    ..Nine months after its implementation a study was carried out to assess whether children below five years of age with uncomplicated malaria were actually receiving AS+AQ...
  22. ncbi Adherence to a six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Uganda
    Carole Fogg
    Epicentre, Paris, France
    Am J Trop Med Hyg 71:525-30. 2004
    ..The high adherence to artemether-lumefantrine found in our study suggest that this drug is likely to be very effective in Mbarara provided that patients receive clear dosage explanations...
  23. ncbi Operational response to malaria epidemics: are rapid diagnostic tests cost-effective?
    Estelle Rolland
    Epicentre, Paris, France
    Trop Med Int Health 11:398-408. 2006
    ..A tolerated incremental cost of 1 euro is probably justified given overall public health and financial benefits. The RDTs should be considered for malaria epidemics if logistics and human resources allow...
  24. ncbi Assessment of three new parasite lactate dehydrogenase (pan-pLDH) tests for diagnosis of uncomplicated malaria
    Carole Fogg
    Epicentre, 8 rue Saint Sabin, 75011, Paris, France
    Trans R Soc Trop Med Hyg 102:25-31. 2008
    ..falciparum malaria, and all pLDH tests became negative after treatment more quickly than the HRP2. Therefore the rapid test of choice for use with artemisinin-combination therapies in this area would be one of these new pLDH tests...
  25. ncbi Malaria epidemics and interventions, Kenya, Burundi, southern Sudan, and Ethiopia, 1999-2004
    Francesco Checchi
    Department of Infectious and Tropical Disease, London School of Hygiene and Tropical Medicine, London, United Kingdom
    Emerg Infect Dis 12:1477-85. 2006
    ....
  26. ncbi Plasmodium vivax resistance to chloroquine in Dawei, southern Myanmar
    Jean Paul Guthmann
    Epicentre, Paris, France
    Trop Med Int Health 13:91-8. 2008
    ..To assess the efficacy of chloroquine in the treatment of Plasmodium vivax malaria in in Dawei District, southern Myanmar...
  27. ncbi Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo
    Sandra Cohuet
    Epicentre, Paris, , Brussels, Belgium; Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium
    Am J Trop Med Hyg 75:152-4. 2006
    ..9% (3/102) in Boende, and 0.9% (1/112) in Basankusu. These results suggest high resistance to pyrimethamine alone or combined with sulfadoxine. Adding artesunate to SP does not seem a valid alternative to the current monotherapy...
  28. ncbi Low efficacy of the combination artesunate plus amodiaquine for uncomplicated falciparum malaria among children under 5 years in Kailahun, Sierra Leone
    Francesco Grandesso
    Epicentre, Paris, France
    Trop Med Int Health 11:1017-21. 2006
    ..In Kailahun a more efficacious combination might be necessary in the future. The efficacy of AS + AQ needs to be monitored in Kailahun and in the other regions of Sierra Leone...
  29. ncbi Outbreak of hepatitis E virus infection in Darfur, Sudan: effectiveness of real-time reverse transcription-PCR analysis of dried blood spots
    Audrey Merens
    National Reference Laboratory for Hepatitis E, Hospital Val de Grâce, Paris, France
    J Clin Microbiol 47:1931-3. 2009
    ..6%). Biological profiles (RT-PCR and serology) of asymptomatic individuals were also analyzed...
  30. ncbi Malaria in camps for internally-displaced persons in Uganda: evaluation of an insecticide-treated bednet distribution programme
    Sebastian Spencer
    , 4 rue Saint Sabin, 75011 Paris, France
    Trans R Soc Trop Med Hyg 98:719-27. 2004
    ..63, 95% CI 0.46-0.87); ITNs with severe damage remained effective (RR for severely damaged net 0.58, 95% CI 0.35-0.98). There was no significant difference in haemoglobin concentration between ITN users and non-users...
  31. ncbi Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad
    Elisabeth Nicand
    National Reference Centre for Hepatitis E, Teaching Military Hospital Val de Grace, Paris, France
    J Med Virol 77:519-21. 2005
    ..7%) to strains belonging to Genotype 1. But four isolates collected in one of the Chadian camps were close to Genotype 2. Circulation of divergent strains argues for possible multiple sources of infection...
  32. ncbi Varying efficacy of artesunate+amodiaquine and artesunate+sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in the Democratic Republic of Congo: a report of two in-vivo studies
    Maryline Bonnet
    Epicentre, Geneva 21, Switzerland
    Malar J 8:192. 2009
    ..Very few data on anti-malarial efficacy are available from the Democratic Republic of Congo (DRC). DRC changed its anti-malarial treatment policy to amodiaquine (AQ) and artesunate (AS) in 2005...
  33. ncbi Risk associated with asymptomatic parasitaemia occurring post-antimalarial treatment
    Piero Olliaro
    UNICEF UNDP World Bank WHO Special Programme on Research and Training in Tropical Diseases TDR, Geneva, Switzerland
    Trop Med Int Health 13:83-90. 2008
    ..Current guidelines recommend treatment only when patients develop symptoms or at the end of follow-up. We wanted to assess prospectively the probability of becoming symptomatic and the risks of this practice...
  34. ncbi In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up
    Kasia Stepniewska
    Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Rd, Bangkok 10400, Thailand
    Antimicrob Agents Chemother 48:4271-80. 2004
    ..94) or if the entomological inoculation rate was known. In the assessment of drug efficacy against falciparum malaria, 28 days should be the minimum period of follow-up...
  35. ncbi Geographical distribution of selected and putatively neutral SNPs in Southeast Asian malaria parasites
    Tim J C Anderson
    Southwest Foundation for Biomedical Research, San Antonio, Texas, USA
    Mol Biol Evol 22:2362-74. 2005
    ..falciparum genome violates the central assumption that selected sites are rare, which complicates identification of outlier loci, and suggests that caution is needed when using this approach...
  36. ncbi Selection strength and hitchhiking around two anti-malarial resistance genes
    Denae Nash
    Southwest Foundation for Biomedical Research (SFBR, San Antonio, TX 78245, USA
    Proc Biol Sci 272:1153-61. 2005
    ..However, the lower levels of LD surrounding resistance alleles in populations under weak selection may simplify identification of functional mutations...
  37. ncbi Death rates from malaria epidemics, Burundi and Ethiopia
    Jean Paul Guthmann
    Institut de Veille Sanitaire, Saint Maurice, France
    Emerg Infect Dis 13:140-3. 2007
    ..Deaths likely from malaria ranged from 1,000 to 8,900, depending on site, and accounted for 52% to 78% of total deaths. Earlier detection of malaria and better case management are needed...
  38. ncbi Efficacy of chloroquine, sulphadoxine-pyrimethamine and amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in Kajo Keji county, Sudan
    Elisa Stivanello
    Medecins Sans Frontieres, Geneva, Switzerland
    Trop Med Int Health 9:975-80. 2004
    ..We recommend a combination of artemether and lumefantrine as first-line treatment for uncomplicated P. falciparum malaria cases in Kajo Keji county...
  39. ncbi Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment
    Kefas Mugittu
    Ifakara Health Research and Development Centre, Ifakara, Tanzania
    Trop Med Int Health 12:219-23. 2007
    ..2%)] and 14 [24/51 (47.1%)]. These results impact significantly on resistance monitoring and point to the value of genotyping all recurrent infections in antimalarial trials...
  40. ncbi Evaluation of three rapid tests for diagnosis of P. falciparum and P. vivax malaria in Colombia
    Ingrid van den Broek
    Médecins sans Frontières MSF, London, UK
    Am J Trop Med Hyg 75:1209-15. 2006
    ..vivax cases as more acceptable than missing some cases of P. falciparum, we recommend careful implementation of NOW-malaria-ICT in areas where microscopy is lacking. The price is however still a constraint...
  41. ncbi Efficacy of three artemisinin combination therapies for the treatment of uncomplicated Plasmodium falciparum malaria in the Republic of Congo
    Ingrid van den Broek
    Medecins Sans Frontieres, London, UK
    Malar J 5:113. 2006
    ..Presented here are the results of a comparative trial on the efficacy of three artemisinin-based combinations conducted from May to October 2004, in Pool Province, Republic of Congo...
  42. ncbi A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites
    Shalini Nair
    Southwest Foundation for Biomedical Research, San Antonio, Texas, USA
    Mol Biol Evol 20:1526-36. 2003
    ....
  43. ncbi High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan
    Delia Boccia
    European Programme for Intervention Epidemiology Training, Stockholm, Sweden
    Clin Infect Dis 42:1679-84. 2006
    ..2%). CONCLUSIONS: This large epidemic of HEV infection illustrates the dramatic impact of this disease on pregnant women. Timely interventions and a vaccine are urgently needed to prevent mortality in this special group...
  44. ncbi Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites
    Mallika Imwong
    Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
    J Infect Dis 195:927-33. 2007
    ..Thus, reappearance of parasitemia after treatment can result from relapse, recrudescence, or reinfection. It has been assumed that parasites causing relapse would be a subset of the parasites that caused the primary infection...